NCT00536497View on ClinicalTrials.gov

Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2007

Conditions
Healthy Subjects
Interventions
DRUG

GW842166X

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY